世界の成長ホルモン欠乏症治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Growth Hormone Deficiency Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z2639 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、90ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、成長ホルモン欠乏症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（薬物療法、組換えヒト成長ホルモン、ヒト下垂体抽出物、手術）、用途別市場規模（病院、診療所、在宅ケア）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・成長ホルモン欠乏症治療の市場動向 ・企業の競争状況、市場シェア ・成長ホルモン欠乏症治療の種類別市場規模（薬物療法、組換えヒト成長ホルモン、ヒト下垂体抽出物、手術） ・成長ホルモン欠乏症治療の用途別市場規模（病院、診療所、在宅ケア） ・成長ホルモン欠乏症治療の北米市場規模2016-2027（アメリカ、カナダ） ・成長ホルモン欠乏症治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・成長ホルモン欠乏症治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・成長ホルモン欠乏症治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・成長ホルモン欠乏症治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Sandoz International、Sanofi Aventis、Pfizer、Novo Nordisk、Teva Pharmaceutical、Ranbaxy、EMD Serono、Sun Pharmaceutical、Eli Lilly） ・結論

Growth hormone deficiency (GHD) is a medical condition characterized by insufficient production of somatropin, a growth hormone, from the anterior pituitary gland which is responsible for the growth and cell reproduction.
The primary factor contributing to the growth of global growth hormone deficiency treatment market is increasing incidence of growth hormone deficiency syndrome. Several other factors which may cause the global growth hormone deficiency market to grow include changing lifestyle, prevalence of other genetic disorders and incidence of GHD in adults.

Market Analysis and Insights: Global Growth Hormone Deficiency Treatment Market
The global Growth Hormone Deficiency Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Growth Hormone Deficiency Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Growth Hormone Deficiency Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Growth Hormone Deficiency Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Growth Hormone Deficiency Treatment market.

Global Growth Hormone Deficiency Treatment Scope and Market Size
Growth Hormone Deficiency Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Growth Hormone Deficiency Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Pharmacological Therapy
Recombinant Human Growth Hormone
Human Pituitary Gland Extracts
Surgery

Segment by Application
Hospitals
Clinics
Home Care Settings

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Sandoz International
Sanofi Aventis
Pfizer
Novo Nordisk
Teva Pharmaceutical
Ranbaxy
EMD Serono
Sun Pharmaceutical
Eli Lilly

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Growth Hormone Deficiency Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Pharmacological Therapy
1.2.3 Recombinant Human Growth Hormone
1.2.4 Human Pituitary Gland Extracts
1.2.5 Surgery
1.3 Market by Application
1.3.1 Global Growth Hormone Deficiency Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Home Care Settings
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Growth Hormone Deficiency Treatment Market Perspective (2016-2027)
2.2 Growth Hormone Deficiency Treatment Growth Trends by Regions
2.2.1 Growth Hormone Deficiency Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Growth Hormone Deficiency Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Growth Hormone Deficiency Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Growth Hormone Deficiency Treatment Industry Dynamic
2.3.1 Growth Hormone Deficiency Treatment Market Trends
2.3.2 Growth Hormone Deficiency Treatment Market Drivers
2.3.3 Growth Hormone Deficiency Treatment Market Challenges
2.3.4 Growth Hormone Deficiency Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Growth Hormone Deficiency Treatment Players by Revenue
3.1.1 Global Top Growth Hormone Deficiency Treatment Players by Revenue (2016-2021)
3.1.2 Global Growth Hormone Deficiency Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Growth Hormone Deficiency Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Growth Hormone Deficiency Treatment Revenue
3.4 Global Growth Hormone Deficiency Treatment Market Concentration Ratio
3.4.1 Global Growth Hormone Deficiency Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Growth Hormone Deficiency Treatment Revenue in 2020
3.5 Growth Hormone Deficiency Treatment Key Players Head office and Area Served
3.6 Key Players Growth Hormone Deficiency Treatment Product Solution and Service
3.7 Date of Enter into Growth Hormone Deficiency Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Growth Hormone Deficiency Treatment Breakdown Data by Type
4.1 Global Growth Hormone Deficiency Treatment Historic Market Size by Type (2016-2021)
4.2 Global Growth Hormone Deficiency Treatment Forecasted Market Size by Type (2022-2027)

5 Growth Hormone Deficiency Treatment Breakdown Data by Application
5.1 Global Growth Hormone Deficiency Treatment Historic Market Size by Application (2016-2021)
5.2 Global Growth Hormone Deficiency Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Growth Hormone Deficiency Treatment Market Size (2016-2027)
6.2 North America Growth Hormone Deficiency Treatment Market Size by Type
6.2.1 North America Growth Hormone Deficiency Treatment Market Size by Type (2016-2021)
6.2.2 North America Growth Hormone Deficiency Treatment Market Size by Type (2022-2027)
6.2.3 North America Growth Hormone Deficiency Treatment Market Size by Type (2016-2027)
6.3 North America Growth Hormone Deficiency Treatment Market Size by Application
6.3.1 North America Growth Hormone Deficiency Treatment Market Size by Application (2016-2021)
6.3.2 North America Growth Hormone Deficiency Treatment Market Size by Application (2022-2027)
6.3.3 North America Growth Hormone Deficiency Treatment Market Size by Application (2016-2027)
6.4 North America Growth Hormone Deficiency Treatment Market Size by Country
6.4.1 North America Growth Hormone Deficiency Treatment Market Size by Country (2016-2021)
6.4.2 North America Growth Hormone Deficiency Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Growth Hormone Deficiency Treatment Market Size (2016-2027)
7.2 Europe Growth Hormone Deficiency Treatment Market Size by Type
7.2.1 Europe Growth Hormone Deficiency Treatment Market Size by Type (2016-2021)
7.2.2 Europe Growth Hormone Deficiency Treatment Market Size by Type (2022-2027)
7.2.3 Europe Growth Hormone Deficiency Treatment Market Size by Type (2016-2027)
7.3 Europe Growth Hormone Deficiency Treatment Market Size by Application
7.3.1 Europe Growth Hormone Deficiency Treatment Market Size by Application (2016-2021)
7.3.2 Europe Growth Hormone Deficiency Treatment Market Size by Application (2022-2027)
7.3.3 Europe Growth Hormone Deficiency Treatment Market Size by Application (2016-2027)
7.4 Europe Growth Hormone Deficiency Treatment Market Size by Country
7.4.1 Europe Growth Hormone Deficiency Treatment Market Size by Country (2016-2021)
7.4.2 Europe Growth Hormone Deficiency Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Growth Hormone Deficiency Treatment Market Size (2016-2027)
8.2 Asia-Pacific Growth Hormone Deficiency Treatment Market Size by Type
8.2.1 Asia-Pacific Growth Hormone Deficiency Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Growth Hormone Deficiency Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Growth Hormone Deficiency Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Growth Hormone Deficiency Treatment Market Size by Application
8.3.1 Asia-Pacific Growth Hormone Deficiency Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Growth Hormone Deficiency Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Growth Hormone Deficiency Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Growth Hormone Deficiency Treatment Market Size by Region
8.4.1 Asia-Pacific Growth Hormone Deficiency Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Growth Hormone Deficiency Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Growth Hormone Deficiency Treatment Market Size (2016-2027)
9.2 Latin America Growth Hormone Deficiency Treatment Market Size by Type
9.2.1 Latin America Growth Hormone Deficiency Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Growth Hormone Deficiency Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Growth Hormone Deficiency Treatment Market Size by Type (2016-2027)
9.3 Latin America Growth Hormone Deficiency Treatment Market Size by Application
9.3.1 Latin America Growth Hormone Deficiency Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Growth Hormone Deficiency Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Growth Hormone Deficiency Treatment Market Size by Application (2016-2027)
9.4 Latin America Growth Hormone Deficiency Treatment Market Size by Country
9.4.1 Latin America Growth Hormone Deficiency Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Growth Hormone Deficiency Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Growth Hormone Deficiency Treatment Market Size (2016-2027)
10.2 Middle East & Africa Growth Hormone Deficiency Treatment Market Size by Type
10.2.1 Middle East & Africa Growth Hormone Deficiency Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Growth Hormone Deficiency Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Growth Hormone Deficiency Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Growth Hormone Deficiency Treatment Market Size by Application
10.3.1 Middle East & Africa Growth Hormone Deficiency Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Growth Hormone Deficiency Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Growth Hormone Deficiency Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Growth Hormone Deficiency Treatment Market Size by Country
10.4.1 Middle East & Africa Growth Hormone Deficiency Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Growth Hormone Deficiency Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Sandoz International
11.1.1 Sandoz International Company Details
11.1.2 Sandoz International Business Overview
11.1.3 Sandoz International Growth Hormone Deficiency Treatment Introduction
11.1.4 Sandoz International Revenue in Growth Hormone Deficiency Treatment Business (2016-2021)
11.1.5 Sandoz International Recent Development
11.2 Sanofi Aventis
11.2.1 Sanofi Aventis Company Details
11.2.2 Sanofi Aventis Business Overview
11.2.3 Sanofi Aventis Growth Hormone Deficiency Treatment Introduction
11.2.4 Sanofi Aventis Revenue in Growth Hormone Deficiency Treatment Business (2016-2021)
11.2.5 Sanofi Aventis Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Growth Hormone Deficiency Treatment Introduction
11.3.4 Pfizer Revenue in Growth Hormone Deficiency Treatment Business (2016-2021)
11.3.5 Pfizer Recent Development
11.4 Novo Nordisk
11.4.1 Novo Nordisk Company Details
11.4.2 Novo Nordisk Business Overview
11.4.3 Novo Nordisk Growth Hormone Deficiency Treatment Introduction
11.4.4 Novo Nordisk Revenue in Growth Hormone Deficiency Treatment Business (2016-2021)
11.4.5 Novo Nordisk Recent Development
11.5 Teva Pharmaceutical
11.5.1 Teva Pharmaceutical Company Details
11.5.2 Teva Pharmaceutical Business Overview
11.5.3 Teva Pharmaceutical Growth Hormone Deficiency Treatment Introduction
11.5.4 Teva Pharmaceutical Revenue in Growth Hormone Deficiency Treatment Business (2016-2021)
11.5.5 Teva Pharmaceutical Recent Development
11.6 Ranbaxy
11.6.1 Ranbaxy Company Details
11.6.2 Ranbaxy Business Overview
11.6.3 Ranbaxy Growth Hormone Deficiency Treatment Introduction
11.6.4 Ranbaxy Revenue in Growth Hormone Deficiency Treatment Business (2016-2021)
11.6.5 Ranbaxy Recent Development
11.7 EMD Serono
11.7.1 EMD Serono Company Details
11.7.2 EMD Serono Business Overview
11.7.3 EMD Serono Growth Hormone Deficiency Treatment Introduction
11.7.4 EMD Serono Revenue in Growth Hormone Deficiency Treatment Business (2016-2021)
11.7.5 EMD Serono Recent Development
11.8 Sun Pharmaceutical
11.8.1 Sun Pharmaceutical Company Details
11.8.2 Sun Pharmaceutical Business Overview
11.8.3 Sun Pharmaceutical Growth Hormone Deficiency Treatment Introduction
11.8.4 Sun Pharmaceutical Revenue in Growth Hormone Deficiency Treatment Business (2016-2021)
11.8.5 Sun Pharmaceutical Recent Development
11.9 Eli Lilly
11.9.1 Eli Lilly Company Details
11.9.2 Eli Lilly Business Overview
11.9.3 Eli Lilly Growth Hormone Deficiency Treatment Introduction
11.9.4 Eli Lilly Revenue in Growth Hormone Deficiency Treatment Business (2016-2021)
11.9.5 Eli Lilly Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Growth Hormone Deficiency Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Pharmacological Therapy
Table 3. Key Players of Recombinant Human Growth Hormone
Table 4. Key Players of Human Pituitary Gland Extracts
Table 5. Key Players of Surgery
Table 6. Global Growth Hormone Deficiency Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Growth Hormone Deficiency Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Growth Hormone Deficiency Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Growth Hormone Deficiency Treatment Market Share by Regions (2016-2021)
Table 10. Global Growth Hormone Deficiency Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Growth Hormone Deficiency Treatment Market Share by Regions (2022-2027)
Table 12. Growth Hormone Deficiency Treatment Market Trends
Table 13. Growth Hormone Deficiency Treatment Market Drivers
Table 14. Growth Hormone Deficiency Treatment Market Challenges
Table 15. Growth Hormone Deficiency Treatment Market Restraints
Table 16. Global Growth Hormone Deficiency Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Growth Hormone Deficiency Treatment Market Share by Players (2016-2021)
Table 18. Global Top Growth Hormone Deficiency Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Growth Hormone Deficiency Treatment as of 2020)
Table 19. Ranking of Global Top Growth Hormone Deficiency Treatment Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Growth Hormone Deficiency Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Growth Hormone Deficiency Treatment Product Solution and Service
Table 23. Date of Enter into Growth Hormone Deficiency Treatment Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Growth Hormone Deficiency Treatment Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Growth Hormone Deficiency Treatment Revenue Market Share by Type (2016-2021)
Table 27. Global Growth Hormone Deficiency Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Growth Hormone Deficiency Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Growth Hormone Deficiency Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Growth Hormone Deficiency Treatment Revenue Market Share by Application (2016-2021)
Table 31. Global Growth Hormone Deficiency Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Growth Hormone Deficiency Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Growth Hormone Deficiency Treatment Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Growth Hormone Deficiency Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Growth Hormone Deficiency Treatment Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Growth Hormone Deficiency Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Growth Hormone Deficiency Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Growth Hormone Deficiency Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Growth Hormone Deficiency Treatment Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Growth Hormone Deficiency Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Growth Hormone Deficiency Treatment Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Growth Hormone Deficiency Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Growth Hormone Deficiency Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Growth Hormone Deficiency Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Growth Hormone Deficiency Treatment Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Growth Hormone Deficiency Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Growth Hormone Deficiency Treatment Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Growth Hormone Deficiency Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Growth Hormone Deficiency Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Growth Hormone Deficiency Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Growth Hormone Deficiency Treatment Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Growth Hormone Deficiency Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Growth Hormone Deficiency Treatment Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Growth Hormone Deficiency Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Growth Hormone Deficiency Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Growth Hormone Deficiency Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Growth Hormone Deficiency Treatment Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Growth Hormone Deficiency Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Growth Hormone Deficiency Treatment Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Growth Hormone Deficiency Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Growth Hormone Deficiency Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Growth Hormone Deficiency Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 63. Sandoz International Company Details
Table 64. Sandoz International Business Overview
Table 65. Sandoz International Growth Hormone Deficiency Treatment Product
Table 66. Sandoz International Revenue in Growth Hormone Deficiency Treatment Business (2016-2021) & (US$ Million)
Table 67. Sandoz International Recent Development
Table 68. Sanofi Aventis Company Details
Table 69. Sanofi Aventis Business Overview
Table 70. Sanofi Aventis Growth Hormone Deficiency Treatment Product
Table 71. Sanofi Aventis Revenue in Growth Hormone Deficiency Treatment Business (2016-2021) & (US$ Million)
Table 72. Sanofi Aventis Recent Development
Table 73. Pfizer Company Details
Table 74. Pfizer Business Overview
Table 75. Pfizer Growth Hormone Deficiency Treatment Product
Table 76. Pfizer Revenue in Growth Hormone Deficiency Treatment Business (2016-2021) & (US$ Million)
Table 77. Pfizer Recent Development
Table 78. Novo Nordisk Company Details
Table 79. Novo Nordisk Business Overview
Table 80. Novo Nordisk Growth Hormone Deficiency Treatment Product
Table 81. Novo Nordisk Revenue in Growth Hormone Deficiency Treatment Business (2016-2021) & (US$ Million)
Table 82. Novo Nordisk Recent Development
Table 83. Teva Pharmaceutical Company Details
Table 84. Teva Pharmaceutical Business Overview
Table 85. Teva Pharmaceutical Growth Hormone Deficiency Treatment Product
Table 86. Teva Pharmaceutical Revenue in Growth Hormone Deficiency Treatment Business (2016-2021) & (US$ Million)
Table 87. Teva Pharmaceutical Recent Development
Table 88. Ranbaxy Company Details
Table 89. Ranbaxy Business Overview
Table 90. Ranbaxy Growth Hormone Deficiency Treatment Product
Table 91. Ranbaxy Revenue in Growth Hormone Deficiency Treatment Business (2016-2021) & (US$ Million)
Table 92. Ranbaxy Recent Development
Table 93. EMD Serono Company Details
Table 94. EMD Serono Business Overview
Table 95. EMD Serono Growth Hormone Deficiency Treatment Product
Table 96. EMD Serono Revenue in Growth Hormone Deficiency Treatment Business (2016-2021) & (US$ Million)
Table 97. EMD Serono Recent Development
Table 98. Sun Pharmaceutical Company Details
Table 99. Sun Pharmaceutical Business Overview
Table 100. Sun Pharmaceutical Revenue in Growth Hormone Deficiency Treatment Business (2016-2021) & (US$ Million)
Table 101. Sun Pharmaceutical Recent Development
Table 102. Eli Lilly Company Details
Table 103. Eli Lilly Business Overview
Table 104. Eli Lilly Growth Hormone Deficiency Treatment Product
Table 105. Eli Lilly Revenue in Growth Hormone Deficiency Treatment Business (2016-2021) & (US$ Million)
Table 106. Eli Lilly Recent Development
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Growth Hormone Deficiency Treatment Market Share by Type: 2020 VS 2027
Figure 2. Pharmacological Therapy Features
Figure 3. Recombinant Human Growth Hormone Features
Figure 4. Human Pituitary Gland Extracts Features
Figure 5. Surgery Features
Figure 6. Global Growth Hormone Deficiency Treatment Market Share by Application: 2020 VS 2027
Figure 7. Hospitals Case Studies
Figure 8. Clinics Case Studies
Figure 9. Home Care Settings Case Studies
Figure 10. Growth Hormone Deficiency Treatment Report Years Considered
Figure 11. Global Growth Hormone Deficiency Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Growth Hormone Deficiency Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Growth Hormone Deficiency Treatment Market Share by Regions: 2020 VS 2027
Figure 14. Global Growth Hormone Deficiency Treatment Market Share by Regions (2022-2027)
Figure 15. Global Growth Hormone Deficiency Treatment Market Share by Players in 2020
Figure 16. Global Top Growth Hormone Deficiency Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Growth Hormone Deficiency Treatment as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Growth Hormone Deficiency Treatment Revenue in 2020
Figure 18. Global Growth Hormone Deficiency Treatment Revenue Market Share by Type (2016-2021)
Figure 19. Global Growth Hormone Deficiency Treatment Revenue Market Share by Type (2022-2027)
Figure 20. North America Growth Hormone Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Growth Hormone Deficiency Treatment Market Share by Type (2016-2027)
Figure 22. North America Growth Hormone Deficiency Treatment Market Share by Application (2016-2027)
Figure 23. North America Growth Hormone Deficiency Treatment Market Share by Country (2016-2027)
Figure 24. United States Growth Hormone Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Growth Hormone Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Growth Hormone Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Growth Hormone Deficiency Treatment Market Share by Type (2016-2027)
Figure 28. Europe Growth Hormone Deficiency Treatment Market Share by Application (2016-2027)
Figure 29. Europe Growth Hormone Deficiency Treatment Market Share by Country (2016-2027)
Figure 30. Germany Growth Hormone Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Growth Hormone Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Growth Hormone Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Growth Hormone Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Growth Hormone Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Growth Hormone Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Growth Hormone Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Growth Hormone Deficiency Treatment Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Growth Hormone Deficiency Treatment Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Growth Hormone Deficiency Treatment Market Share by Region (2016-2027)
Figure 40. China Growth Hormone Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Growth Hormone Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Growth Hormone Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Growth Hormone Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Growth Hormone Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Growth Hormone Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Growth Hormone Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Growth Hormone Deficiency Treatment Market Share by Type (2016-2027)
Figure 48. Latin America Growth Hormone Deficiency Treatment Market Share by Application (2016-2027)
Figure 49. Latin America Growth Hormone Deficiency Treatment Market Share by Country (2016-2027)
Figure 50. Mexico Growth Hormone Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Growth Hormone Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Growth Hormone Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Growth Hormone Deficiency Treatment Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Growth Hormone Deficiency Treatment Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Growth Hormone Deficiency Treatment Market Share by Country (2016-2027)
Figure 56. Turkey Growth Hormone Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Growth Hormone Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Growth Hormone Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Sandoz International Revenue Growth Rate in Growth Hormone Deficiency Treatment Business (2016-2021)
Figure 60. Sanofi Aventis Revenue Growth Rate in Growth Hormone Deficiency Treatment Business (2016-2021)
Figure 61. Pfizer Revenue Growth Rate in Growth Hormone Deficiency Treatment Business (2016-2021)
Figure 62. Novo Nordisk Revenue Growth Rate in Growth Hormone Deficiency Treatment Business (2016-2021)
Figure 63. Teva Pharmaceutical Revenue Growth Rate in Growth Hormone Deficiency Treatment Business (2016-2021)
Figure 64. Ranbaxy Revenue Growth Rate in Growth Hormone Deficiency Treatment Business (2016-2021)
Figure 65. EMD Serono Revenue Growth Rate in Growth Hormone Deficiency Treatment Business (2016-2021)
Figure 66. Sun Pharmaceutical Revenue Growth Rate in Growth Hormone Deficiency Treatment Business (2016-2021)
Figure 67. Eli Lilly Revenue Growth Rate in Growth Hormone Deficiency Treatment Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed

---